“Following a streamlined review, an app can be added to a...

“Following a streamlined review, an app can be added to a central registry of apps that can be prescribed by physicians and psychotherapists and will be reimbursed by all of Germany’s statutory health insurance providers, which cover 90% of the population, or roughly 73 million individuals. The Fast-Track Process is run by the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, or BfArM), which plays many of the same roles in Germany that the FDA does in the United States); BfArM also maintains the DiGA registry. The first five apps have already been added to the registry and offer support for patients to manage conditions including tinnitus, obesity, agoraphobia, osteoarthritis, and insomnia.”

Interesting that Germany have developed a fast tracked regulatory pathway to bring digital health applications to market. Who are we working with HQd in Germany?

https://hbr.org/2020/12/want-to-see-the-future-of-digital-health-tools-look-to-germany